Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Are Local Drug Controls Depressing for the Pharmaceutical Industry?
Motley Fool
Thursday, January 24, 2013 - 6:42pm
tags:
Pfizer, Mylan, Covidien
Merck Is Still A Long-Term Hold Despite Tredaptive Suspension
Seeking Alpha
Thursday, January 24, 2013 - 6:41pm
tags:
Merck, Tredaptive
Pfizer Fourth Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Thursday, January 24, 2013 - 6:40pm
tags:
earnings, Pfizer
Baxter snags hemophilia candidate in $185M deal with Ipsen and broke biotech
Fierce Biotech
Thursday, January 24, 2013 - 11:32am
tags:
Baxter International, Ipsen, hemophilia
Cellceutix Reports In Vivo Tumor Shrinkage in Renal Cancer
Yahoo
Thursday, January 24, 2013 - 11:12am
tags:
Cellceutix, renal cancer, Kevetrin
Watson buys Uteron of Belgium in $305 million deal
Pharma Times, UK
Thursday, January 24, 2013 - 10:42am
tags:
Uteron, Belgium, Watson Pharmaceuticals, M&A
Merck CEO says jury out on raising good cholesterol
Yahoo/Reuters
Thursday, January 24, 2013 - 10:41am
tags:
Merck, Kenneth Frazier, Tredaptive
FDA approves new use for Roche's Avastin in colon cancer treatment
Reuters
Thursday, January 24, 2013 - 10:40am
tags:
Roche, FDA, Avastin, colorectal cancer
Gilead Petitions FDA Over Its Stribild AIDS Med
Pharmalot
Thursday, January 24, 2013 - 10:39am
tags:
FDA, Stribild, AIDS, Gilead
US Investigates Novartis Over Alcon Sales To Iran
Pharmalot
Thursday, January 24, 2013 - 10:38am
tags:
Novartis, Alcon, Iran
Amgen 4Q profit drops 16 pct. on higher spending
Yahoo/AP
Thursday, January 24, 2013 - 10:37am
tags:
earnings, Amgen
Alnylam: Rally On No News Leaves Room For Downside
Seeking Alpha
Thursday, January 24, 2013 - 10:35am
tags:
Alnylam, Isis Pharmaceuticals
Biogen’s Longer-Lasting MS Drug Meets Goals in Late Trial
Bloomberg
Thursday, January 24, 2013 - 10:33am
tags:
MS, Biogen Idec, multiple sclerosis, peginterferon beta-1a
Celgene Earnings: These Results Have Investors Guessing
Wall St. Cheat Sheet
Thursday, January 24, 2013 - 10:31am
tags:
earnings, Celgene
Arena Stumbles On EMA Concerns Over Belviq Ahead Of Launch
Seeking Alpha
Thursday, January 24, 2013 - 10:30am
tags:
Europe, Belviq, Arena Pharmaceuticals
Amarin announces market introduction of Vascepa capsules for treatment of VHTG
Yahoo/Fly on the Wall
Thursday, January 24, 2013 - 10:29am
tags:
Amarin, Vascepa
The Market Waits For NovaBay
Seeking Alpha
Thursday, January 24, 2013 - 10:28am
tags:
NovaBay
1 Undervalued Generic Producer and 1 Peer Stock With Momentum
Motley Fool
Thursday, January 24, 2013 - 10:27am
tags:
generics, Mylan, Teva
Cubist Pharma Earnings: A Mixed Reaction to Analyst Estimates
Wall St. Cheat Sheet
Thursday, January 24, 2013 - 10:27am
tags:
earnings, Cubist Pharmaceuticals
AstraZeneca: Results Preview
Motley Fool
Thursday, January 24, 2013 - 10:25am
tags:
earnings, Astra Zeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.